FactSentinel

Willow bark has been used for pain and fever relief for thousands of years, with records of its use dating back to ancient Egypt, Greece, and China. Practitioners chewed the bark or brewed it into teas to treat aches, inflammation, and fevers. The active compound responsible for these effects is salicin, which the body converts into salicylic acid. In the 19th century, chemists isolated salicin and began studying its therapeutic properties more rigorously, laying the groundwork for modern pharmacology's interest in the substance.

The direct link to aspirin came in 1897, when Felix Hoffmann, a chemist at the German company Bayer, synthesized a more stable and less irritating derivative of salicylic acid called acetylsalicylic acid. This compound retained the pain-relieving and anti-inflammatory benefits of the natural willow bark extract while reducing the stomach irritation associated with salicylic acid itself. Bayer marketed this new compound under the brand name Aspirin in 1899, and it remains one of the most widely used drugs in the world today.

A common misconception is that aspirin is simply willow bark in pill form, but this is inaccurate. The bark's natural compound, salicin, is chemically related to but distinct from the synthesized acetylsalicylic acid found in aspirin tablets. The willow bark tradition provided the scientific inspiration and starting point for research, but the final product was chemically modified and manufactured to improve safety and effectiveness. This progression from natural remedy to refined pharmaceutical is well documented in the history of medicine and is widely accepted among historians and scientists alike.